Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Strongest human evidence The METAOD006 (OPTIONS) Phase 2b trial randomized 502 adults with obesity (BMI 30-45 kg/m^2) to oral AOD-9604 (0.25, 0.5, or 1 mg/day) or placebo for 24 weeks alongside a supervised diet and exercise program
AOD-9604 is supplied to qualified research professionals for in vitro laboratory study
In 2016, 94% of measurements were conducted in the public healthcare system, compared to only 6% in the private sector
Typically, intramuscular injections might be given daily during the first week, followed by weekly shots for one month, and then every month or two months for life
Jonathann Kuo, MD
US$ 28.85
US$ 21.15
US$ 23.26
US$ 21.03
US$ 20.52
US$ 24.80
US$ 27.35
US$ 22.05
